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 BACKGROUND 
•Fascioliasis is a food borne disease caused by infection with a liver fluke termed Fasciola (F.) hepatica. Fascioliasis, as 
a neglected tropical disease, commonly affects poor people from developing countries. It has been estimated that at 
least 2.6 million people are infected with fascioliasis worldwide.  
•According to the International Agency for Research on Cancer, two other liver flukes Opistorchis viverrini and 
Clonorchis sinensis) have been recognized as definitive causes of cancer (IARC, 2012).  
•On the other hand even long-lasting and/or repeated F. hepatica infections have not been associated with cancer, so 
far. There are any known causative associations between this parasite and cholangiocarcinoma or liver cancer.  
Fig. 1: Fasciola haepatica life cycle. 
METHODOLOGICAL STRATEGY 
RESULTS 
CONCLUSIONS 
 Chine Hamster Ovary (CHO) cells were treated with F. hepatica extracts and cell proliferation was assessed by using the indirect method for estimating cell number based on the mitochondrial 
dehydrogenase activity, which reduces sodium 2,3-bis[2-Methoxy-4-nitro-5-sulfophenyl]-2H-tetrazolium-5-carboxyanilide inner salt) with MTS cell proliferation reagent. 
 
•We now hypothesize that some molecules contained in F hepatica extracts could have a potential as a preventive or even curative anti-cancer substance. 
 
AIM 
To investigate the oncogenic role of F. hepatica extracts. 
Surprisingly we observed unexpected death of CHO cells when treated with F. hepatica extracts. 
Fig. 2: Cell proliferation assay of Fasciola haepatica and Schistosoma haematobium extracts-treated cells. The growth curve shows that treated cells with F. hepatica showed no growth while cells 
treated with S. haematobium proliferated significantly faster and more than control cells (Left panel). Trypan exclusion assay of control and F. hepatica and S. haematobium-treated cells. We 
confirmed the induced necrosis of CHO cells when treated with F. haepatica extracts and increase in cell viability when treated with S. haematobium extracts by trypan exclusion assay. (Right 
panel).  
